Диссертация (1140752), страница 18
Текст из файла (страница 18)
–2012. –Vol.58. – №7-8. –P. 805-810.143.Schirra J., Wank U., Arnold R., Göke B., Katschinski M. Effects ofglucagonlike peptide-1 (7-36) amide on motility and sensation of the proximalstomach in humans. Gut 2002; 50:341-8144.Schwenger K. J., Allard J. P. Clinical approaches to non-alcoholic fattyliver disease. World J Gastroenterol 2014; 20:1712-23.145.Schafmayer С., Hartleb J, Tepel J.
Predictors of gallstone composition in1025 symptomatic gallstones from Northern German// BMC Gastroenterol.Published online 2006 Nov 22. doi: 10.1186/1471-230X-6-36146.Schmidt М., Søndenaa K., Dumot J.A.. Post-cholecystectomy symptomswere caused by persistence of a functional gastrointestinal disorder// World JGastroenterol. –2012. – Vol.
– 18. – №12. – Р.1365–1372.147.Shulman G.L., Rothman D. L., Shulman R. G., Brindle K. NMR Studies ofGlucose Disposal in Normal and Non-Insulin-Dependent Diabetic Humans [andDiscussion] // Philosophical Nansactions A. – 1990. – Vol. 333. – № 1632. – Р525-529.148.Simon-Holtorf J1, Mönig H, Klomp HJ, Reinecke-Lüthge A, Fölsch UR,Kloehn S.
Expression and distribution of prolactin receptor in normal, fibrotic,and cirrhotic human liver // Experimental and Clinical Endocrinology &Diabetes. – 2006. – Vol. 10. – №114. – Р 584-589.115149.Spengler E.K., Loomba R. Recommendations for Diagnosis, Referral forLiver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease andNonalcoholic Steatohepatitis. Mayo Clin Proc. 2015 Sep;90(9):1233-46. doi:10.1016/j.mayocp.2015.06.013.
Epub 2015 Jul 26.150.Stewart J. E., Feinle-Bisset C., Keast R.S. Fatty acid detection during foodconsumption and digestion: Associations with ingestive behavior and obesity.Prog Lipid Res 2011; 50:225-33151.Srivastava A., Sharma K., Srivastava N. et ol. Significant Role of Estrogenand Progesterone Receptor Sequence Variants in Gallbladder CancerPredisposition: A Multi-Analytical Strategy // PLoS One. 2012; 7(7): e40162.( Jul10. doi: 10.1371/journal.pone.0040162 )152.Stinton LM, Myers RP, Shaffer EA.
Epidemiology ofgallstones//Gastroenterol Clin North Am. – 2010. – Vol. 39. – № 2. – Р 157-169.153.Stefănescu G, Bălan G, Stanciu C. The relationship between bile reflux andsymptoms in patients with gallstones before and after cholecystectomy// Rev MedChir Soc Med Nat Iasi. – 2009. – Vol. 113. – № 3. – Р.698-703.154.Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, MoodieML, Gortmaker SL. The global obesity pandemic: shaped by global drivers andlocal environments.
Lancet. 2011;378:804–814. [PubMed]155.Tönjes A., Wittenburg H., Halbritter J. et ol. Effects of SLC10A2 variantrs9514089 on gallstone risk and serum cholesterol levels- meta-analysis of threeindependent cohorts// BMC Med Genet. – 2011. –Vol.17. –№12. – 149.156.Utsunomiya N., Tanaka M., Ogawa Y. et al. Pain associated with phase IIIof the duodenal migrating motor comple–x in patients with postcholecystectomybiliary dyskinesia //Gastrointest. Endosc. – 2000.
– Vol. 5, N51.– Р.8.157.Verma I., Sood R., Juneja S., Kaur S.Prevalence of hypothyroidism ininfertile women and evaluation of response of treatment for hypothyroidism oninfertility // Int J Appl Basic Med Res. – 2012. –Vol.2. –№1. –Р.17-19.116158.Videla L.A., Tapia G., Rodrigo R., Pettinelli P., Haim D. Liver NF-kappaBand AP-1 DNA binding in obese patients //Obesity (Silver Spring) . – 2009. –Vol.17. –№5. –Р.973-979.159.Vuppalanci R et al. Nonalcoholic fatty liver disease and non-alcoholicsteatohepatitis: selected practical issues in thear management // Hepatology.2009.
–№ 49. – P.306-317.160.Vyakaranam S.,Vanaparthy S. et ol. Study of Insulin Resistance inSubclinical Hypothyroidism // International Journal of Health Sciences andResearch. – 2014. –Vol.4. –№9. –Р.147-153.161.Wang Н., Min Liu, Clegg Deborah J. et ol. New insights into the molecularmechanisms underlying effects of estrogen on cholesterol gallstone formation //Biochim Biophys Acta. –2009. –Vol.179. –№11. – 1037–1047.162.Wang David Q-H., Cohen David E, Carey M.
C. et ol. Biliary lipids andcholesterol gallstone disease // J Lipid Res. 2009.doi: 10.1194/jlr.R800075JLR200163.Wisén O., Johansson C. Gastrointestinal function in obesity: motility,secretion, and absorption following a liquid test meal. Metabolism 1992; 41:390-5164.Wit N.J., Afman L.A., Mensink M. et al. Phenotyping the effect of diet onnonalcoholic fatty liver disease // J.
Hepatol. – 2012. – Vol. 57, N 6. – P. 1370–1373.165.Wong V.W., Chu W.C., Wong G.L. et al. Prevalence of non-alcoholic fattyliver disease and advanced fibrosis in Hong Kong Chinese: a population studyusing protonmagnetic resonance spectroscopy and transient elastography // Gut. –2012.
– Vol. 61, N 3. – P. 409–415.166.Wu W. C., Zhao W., Li S. Small intestinal bacteria overgrowth decreasessmall intestinal motility in the NASH rats. Wold J Gastroenterol 2008; 14:313-7167.Yener O., Aksoy F., Demır M., Özçelık A., Erengül C. Gallstonesassociated with nonalcoholic steatohepatitis (NASH) and metabolicsyndrome//Turk J Gastroenterol.
–2010. – Vol. 21. – N4.– Р.411-5.117168.Yusuf Yilmaz, Talat Ayyildiz , Hakan Akin et ol. Gallstone Disease DoesNot Predict Liver Histology in Nonalcoholic Fatty Liver Disease // Gut and Liver.– 2014. – Vol. 8. – №. 3. – Р. 313-317169.Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M1,2.Global Epidemiology of Non-Alcoholic Fatty Liver Disease-Meta-AnalyticAssessment of Prevalence, Incidence and Outcomes.
Hepatology. 2015 Dec 28.doi: 10.1002/hep.28431.170.ZhanZhan Li et al. Prevalence of non-alcoholic fatty liver disease inmainland of China: A meta-analysis of published studies // Journal ofgastroenterology and hepatology. – 2014.
–№ 29. – Р.42-51.171.Antonio Ramos-De la Medina et al. Routine Liver Biopsy to screen forNon-alcoholic Fatty liver Disease (NAFLD) during Cholecystoectomy forgallstone disease: Is it Justified? J. Gastrointestinal Surg. 2008 (12): 2097-2102172.Loria P et al. Gallstone disease in non-alcoholic fatty liver: prevalence andassociated factors. J. gastroenterol Hepatol. 2005; 8:1176-1184.173.Nies V.J., Sancar G., Liu W. et ol. Fibroblast Growth Factor Signaling inMetabolic Regulation // Front Endocrinol (Lausanne). 2016 Jan 19;6:193. doi:10.3389/fendo.2015.00193. eCollection 2015..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
